INVENTIVA: Combined General Meeting of May 25, 2023. Availab

Daix (France), Long Island City (New York, United States), May 4, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

Related Keywords

Le Jura , France General , France , Brunswick , Niedersachsen , Germany , Ukraine , United States , Russia , Daix , Bourgogne , New York , French , Aude Lepreux , Pascaline Clerc , Patricial Bank , Brunswick Group , Global External Affairs , Nasdaq , Exchange Commission On , Long Island City , Euronext Paris , Combined General Meeting , Oceania Le Jura , Exchange Commission , French Commercial Code , Rue De Dijon , Combined General , General Meeting , Global External , Roquet Montegon , Private Securities Litigation Reform Act , New Drug Application , Universal Registration Document , Des March , Annual Report , Inventiva , Combined , Eneral , Meeting , 023 , Availability , Preparatory , Documents ,